Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI) Jun 9, 2025 07:13AM
Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI) Jun 2, 2025 06:39AM
Cantor Fitzgerald Reiterates Overweight Rating on TriSalus Life Sciences, Inc. (TLSI) May 19, 2025 06:41AM
Cantor Fitzgerald newsletter says Elutia best, Anteris worst performer Mar 17, 2025 07:38AM
TriSalus Life Sciences (TLSI) Secures $50M Debt Financing with OrbiMed Apr 30, 2024 04:36PM


Apr 30, 2024 04:35PM TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives